Irene Helenowski

8.8k total citations
232 papers, 5.7k citations indexed

About

Irene Helenowski is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Irene Helenowski has authored 232 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 63 papers in Surgery and 54 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Irene Helenowski's work include Lymphoma Diagnosis and Treatment (25 papers), Breast Cancer Treatment Studies (16 papers) and Glioma Diagnosis and Treatment (14 papers). Irene Helenowski is often cited by papers focused on Lymphoma Diagnosis and Treatment (25 papers), Breast Cancer Treatment Studies (16 papers) and Glioma Diagnosis and Treatment (14 papers). Irene Helenowski collaborates with scholars based in United States, Philippines and Egypt. Irene Helenowski's co-authors include Alfred Rademaker, Borko Jovanovic, Melina R. Kibbe, Andrew M. Evens, Susan Yount, Neel A. Mansukhani, Leo I. Gordon, Teresa K. Woodruff, Cord Sturgeon and Benjamin J. Peipert and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Irene Helenowski

224 papers receiving 5.6k citations

Peers

Countries citing papers authored by Irene Helenowski

Since Specialization

Citations

This map shows the geographic impact of Irene Helenowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Helenowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Helenowski more than expected).

Fields of papers citing papers by Irene Helenowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irene Helenowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Helenowski. The network helps show where Irene Helenowski may publish in the future.

Co-authorship network of co-authors of Irene Helenowski

This figure shows the co-authorship network connecting the top 25 collaborators of Irene Helenowski. A scholar is included among the top collaborators of Irene Helenowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irene Helenowski. Irene Helenowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers 2024 ·American Journal of Hematology ·Yasmin Abaza, Eric S. Winer, Guru Subramanian Guru Murthy, Rory M. Shallis, Andrew Matthews, Talha Badar, (unknown), Vamsi Kota, Alok Swaroop, (unknown), (unknown), Irene Helenowski, Yingzhe Liu, Hui Zhang, Annie Im, Mark R. Litzow, Alexander E. Perl, Ehab Atallah, Jessica K. Altman	12
2	Is state trauma funding associated with mortality among injured hospitalized patients? 2023 ·The American Journal of Surgery ·(unknown), (unknown), Irene Helenowski, Jane L. Holl, Renee Y. Hsia, Amy E. Liepert, Robert C. Mackersie, Anne M. Stey	1
3	Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC) 2023 ·British Journal of Cancer ·Devalingam Mahalingam, Siqi Chen, Ping Xie, Houra Loghmani, (unknown), Aparna Kalyan, Sheetal Kircher, Irene Helenowski, Xinlei Mi, (unknown), Matt Coffey, Mary F. Mulcahy, Al B. Benson, Bin Zhang	12
4	Therapy‐related myeloid neoplasms with normal karyotype show distinct genomic and clinical characteristics compared to their counterparts with abnormal karyotype 2022 ·British Journal of Haematology ·(unknown), (unknown), (unknown), (unknown), Jeremy Segal, Sandeep Gurbuxani, Irene Helenowski, Hui Zhang, Madina Sukhanova, Xinyan Lu, Jessica K. Altman, (unknown), Amir Behdad	8
5	Development and Validation of a Nomogram to Predict Lymphedema After Axillary Surgery and Radiation Therapy in Women With Breast Cancer From the NCIC CTG MA.20 Randomized Trial 2019 ·International Journal of Radiation OncologyBiologyPhysics ·Jeffrey P. Gross, Timothy J. Whelan, Wendy R. Parulekar, Bingshu E. Chen, Alfred Rademaker, Irene Helenowski, Eric D. Donnelly, Jonathan Strauss	38
6	Stereotactic radiosurgery for the treatment of brain metastasis from gastrointestinal primary cancers. 2019 ·Europe PMC (PubMed Central) ·(unknown), Irene Helenowski, Liam Kane, Sean Sachdev, Orin Bloch, Matthew C. Tate, James P. Chandler, Tim J. Kruser	5
7	Cost analysis of bronchoalveolar lavage and respiratory tract biopsies in the diagnosis and management of suspected invasive fungal infection in children with cancer or who have undergone stem cell transplant 2019 ·Pediatric Blood & Cancer ·Jenna Rossoff, (unknown), Irene Helenowski, (unknown), Ben Z. Katz, Nobuko Hijiya	9
8	A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2<sup>+</sup> breast cancer 2019 ·Drug Design Development and Therapy ·Ricardo Costa, Saif Zaman, Susan C. Sharpe, Irene Helenowski, (unknown), Hyo S. Han, (unknown), Brian J. Czerniecki	14
9	Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma 2018 ·Journal of Clinical Oncology ·Andrew M. Evens, Ranjana H. Advani, Irene Helenowski, Michelle A. Fanale, Sonali M. Smith, Borko Jovanovic, Gregory Bociek, Andreas K. Klein, Jane N. Winter, Leo I. Gordon, Paul A. Hamlin	96
10	Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus 2018 ·Rheumatology International ·(unknown), (unknown), Joan S. Chmiel, Dorothy D. Dunlop, Irene Helenowski, Pamela A. Semanik, Jing Song, Susan Yount, Rowland W. Chang, Rosalind Ramsey‐Goldman	9
11	Evidence-Based Bundled Quality Improvement Intervention for Reducing Surgical Site Infection in Lower Extremity Vascular Bypass Procedures 2018 ·Journal of the American College of Surgeons ·Katherine Hekman, Eriberto Michel, Eddie Blay, Irene Helenowski, Andrew W. Hoel	15
12	Overweight and Obese Pediatric Patients Have an Increased Risk of Developing a Surgical Site Infection 2016 ·Surgical Infections ·Brian P. Blackwood, Colin D. Gause, Jamie Harris, Christina M. Theodorou, Irene Helenowski, Timothy B. Lautz, Julia Grabowski, Catherine J. Hunter	13
13	REST Is a Novel Prognostic Factor and Therapeutic Target for Medulloblastoma 2012 ·Molecular Cancer Therapeutics ·Pete Taylor, Jason Fangusaro, Veena Rajaram, Stewart Goldman, Irene Helenowski, Tobey J. MacDonald, Martin Hasselblatt, Lars Riedemann, Álvaro Macedo Laureano, Laurence J.N. Cooper, Vidya Gopalakrishnan	40
14	Soy Isoflavone Supplementation for Breast Cancer Risk Reduction: A Randomized Phase II Trial 2012 ·Cancer Prevention Research ·Seema A. Khan, Robert T. Chatterton, (unknown), (unknown), Oukseub Lee, David Ivancic, Richard E. Heinz, Carola M. Zalles, Irene Helenowski, Borko Jovanovic, Adrian A. Franke, Maarten C. Bosland, Jun Wang, Nora Hansen, Kevin P. Bethke, Alexander Dew, (unknown), Raymond C. Bergan	126
15	On Imputing Binary Data via Pairwise Associations and Corresponding Conditional Probabilities 2012 ·Irene Helenowski, Hakan Demirtaş, Beyza Doğanay Erdoğan	2
16	Multicenter Analysis of Elderly Hodgkin Lymphoma (eHL): Outcomes and Prognostic Factors in the Modern Era 2011 ·Blood ·Andrew M. Evens, Irene Helenowski, Chadi Nabhan, Erika Ramsdale, June M. McKoy, Annette K. Larsen, (unknown), Benjamin M. Parsons, Reem Karmali, Britt Hanson, Leo I. Gordon, Scott E. Smith, Stephanie A. Gregory, (unknown), (unknown)	0
17	The Novel Expanded Porphyrin, Motexafin Gadolinium, Combined with [90Y]Ibritumomab Tiuxetan for Relapsed/Refractory Non-Hodgkin's Lymphoma: Preclinical Findings and Results of a Phase I Trial 2009 ·Clinical Cancer Research ·Andrew M. Evens, William G. Spies, Irene Helenowski, David R. Patton, Stewart Spies, Borko Jovanovic, (unknown), Elizabeth Hamilton, Daina Variakojis, Jun Chen, Louie Naumovski, Steven T. Rosen, Jane N. Winter, Richard Miller, Leo I. Gordon	15
18	Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group 2009 ·Clinical Cancer Research ·Chiang‐Ching Huang, Samantha Gadd, Norman E. Breslow, Colleen Cutcliffe, Simone Treiger Sredni, Irene Helenowski, Jeffrey S. Dome, Paul E. Grundy, Daniel M. Green, Michael K. Fritsch, Elizabeth J. Perlman	43
19	Dietary Genistein Inhibits Metastasis of Human Prostate Cancer in Mice 2008 ·Cancer Research ·Minalini Lakshman, Li Xu, Vijayalakshmi Ananthanarayanan, J. C. Cooper, Chris H. Takimoto, Irene Helenowski, Jill C. Pelling, Raymond C. Bergan	135
20	Gene profiling of genistein’s effect in men with prostate cancer. 2006 ·Cancer Research ·Yongzeng Ding, Li Xu, Shan Chen, William J. Catàlona, David L. Kelly, Borko Jovanovic, Irene Helenowski, Ximing J. Yang, Michael Pins, Raymond C. Bergan	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact